Abstract
Remdesivir is an intravenous inhibitor of the viral RNA-dependent RNA polymerase with in vitro and in vivo activity against Middle East respiratory syndrome coronavirus, severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) and SARS-CoV-2.[1][1]–[3][2] In Canada, it is authorized and
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
